Boehringer Ingelheim and the Mary Tyler Moore Vision Initiative (MTM Vision) today jointly announce the start of a long-term ...
More than 530 million people worldwide living with diabetes are at risk for developing diabetic retinal disease (DRD), the leading cause of blindness in working-age adults. 1·DRD is a growing epidemic ...
STORY German pharmaceutical company sees great benefits from CIIE spillover effectSHOOTING TIME Recent footageDATELINE Nov 10 2024LENGTH 00011 ...
Recent funding rounds in the digital health arena feature digital pathology startup Aignostics, remote care specialists TCC, ...
No. 49 / 2024Zealand Pharma Announces Financial Results for the First Nine Months of 2024Continued strong progress across ...
You’ll also find an educational booth hosted by Boehringer Ingelheim, featuring an interactive website full of resources ...
Boehringer Ingelheim’s commitment to our pre-competitive Consortium ... Please be aware that information relating to the approval status and labels of approved products may vary from country to ...
Drugs from Eli Lilly and Boehringer Ingelheim grabbed the spotlight at ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and ...
Hung Nhon Group, a major Vietnamese agricultural corporation, and France's Olmix Group signed a memorandum of understanding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback